Evofem Biosciences Posts Corporate Presentation (Regulation FD)

What Happened
Evofem Biosciences, Inc. filed a Current Report on Form 8-K on July 20, 2026 (Item 7.01) to disclose that it has posted its current corporate slide presentation to the "Investors" section of its website (www.evofem.com). The slides are attached to the 8-K as Exhibit 99.1 and were prepared as of July 20, 2026. The company stated it does not undertake any obligation to update, supplement or amend the presentation.

Key Details

• Filing date: July 20, 2026 (Form 8-K, Item 7.01 – Regulation FD disclosure).
• Exhibit: 99.1 — corporate slide presentation prepared as of July 20, 2026.
• The presentation is posted on the company’s investor website: www.evofem.com.
• Company disclaimers: no obligation to update or amend the posted slides.

Why It Matters
This 8-K makes the company’s latest corporate overview and messaging publicly available to all investors at the same time, consistent with Regulation FD. For investors, the slide deck is a primary source for up-to-date corporate information (strategy, pipeline highlights, or recent milestones) as presented by management; however, the filing itself does not report financial results, executive changes, or other material transactions. Review the posted presentation directly for any new operational or strategic details.